Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats. - Wikidata - awgldk - TriplyDB

Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats.

Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats.

http://www.wikidata.org/entity/Q41684948

about

Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats.Progressive chronic heart failure slows the recovery of microvascular O2 pressures after contractions in the rat spinotrapezius muscle.Acute inhibition of ATP-sensitive K+ channels impairs skeletal muscle vascular control in rats during treadmill exercise.Effects of aging, TNF-α, and exercise training on angiotensin II-induced vasoconstriction of rat skeletal muscle arterioles.The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise.Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases.Effect of nitric oxide on exercise-induced proteinuria in rats.Effects of chronic heart failure on skeletal muscle capillary hemodynamics at rest and during contractions.Role of Nitric Oxide in the Cardiovascular and Renal Systems

P2860

Q33576908-0698DC5E-6191-423D-9B0F-29A59C6BAAC8 Q34426239-C451E018-1E0F-4383-AAC0-8D5AE7C8D043 Q35671721-ECB58271-8AA0-4DC8-BA65-1B6836F88D6E Q36366824-D008CCBB-30E3-4168-B69B-160FE7C8DAEF Q37361567-3DB77EF9-E4DB-4D3B-8A8C-ECCA7B551F07 Q41734131-EE7F27BE-4617-40BA-8088-4B847679DE4D Q43576022-32355872-A715-4986-B8A7-8469B0F7F179 Q44519388-28F5CF54-795B-4157-BDCD-EE4F7B448DC6 Q52017015-27E49D89-E550-4BB9-A4DC-BC2742A648BD Q58766337-92E3626D-EAB3-4034-9A3E-56B69F9A4293

P2860

Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats.

http://www.wikidata.org/entity/Q41684948

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Interactions between angiotens ...... normal and heart failure rats.

@en

type

label

Interactions between angiotens ...... normal and heart failure rats.

@en

prefLabel

Interactions between angiotens ...... normal and heart failure rats.

@en

P1433

Q41684948-5872CC8B-568F-4B94-885D-18BC12509F56

P1476

Q41684948-0BD7B543-0A37-4992-9C89-563547C99FCB

P2093

Q41684948-4CFFEEB3-5774-4D26-958A-98FD786F6E4E

Q41684948-8659F15D-BCDE-44CE-AD24-0B89A196ACE5

Q41684948-A7DEA1C7-9D3C-4788-ABD5-E6DB7A5F4841

P2860

Q41684948-09B97D97-0033-4EBF-AD17-111B0BC88F01

Q41684948-183C8549-3F02-4195-9B35-41827C3911C0

Q41684948-4801E186-53A9-44B7-AA98-F7867EFAEC2A

Q41684948-49633DED-2963-4E13-8E8E-270BA1C2B387

Q41684948-4D7ECBB1-DEBC-4839-B81F-0456EA67B00F

Q41684948-65A7E092-42B2-4ACE-8FB3-5FF4E6DE868D

Q41684948-68116F67-91E5-4427-A8D1-C071EE339DC9

Q41684948-7BC2339C-361F-4B43-8B34-4480EFDB5E05

Q41684948-8171B649-6221-452F-845C-FFF83DDB67B9

Q41684948-8214FEED-C35A-47F9-9D3F-3EFA725285E4

P304

Q41684948-DFB9FB19-4B80-4893-8328-2FDA5E2C2DFE

P31

Q41684948-3462822A-FFD9-4588-8860-ABC53C8694B4

P356

Q41684948-FA2A3A2B-6F7C-4DA6-B2F6-C2B2CFB658FB

P407

Q41684948-A33E4670-3EF5-4004-BFBA-36406C95B8BD

P433

Q41684948-A827278B-DF24-4AD4-9E83-57097FCFBA9A

P478

Q41684948-666BEACF-3A75-4BA5-B8A5-35450BC6B36E

P577

Q41684948-A17C61D7-A694-4CC3-86E9-178918B35DC9

P698

Q41684948-B8BBEAD2-B63F-47E8-A21F-CA78A7002843

P921

Q41684948-A6557075-9184-48C2-989D-63AEA562C704

P356

JAPPL.1999.87.2.574

P1433

Journal of Applied Physiology

P1476

Interactions between angiotens ...... normal and heart failure rats.

@en

P2093

C L Stebbins

http://www.w3.org/2001/XMLSchema#string

J D Symons

http://www.w3.org/2001/XMLSchema#string

T I Musch

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacology of nonpeptide angiotensin II receptor antagonists.

Endothelial function in congestive heart failure.

Regional blood flow responses to acute ANG II infusion: effects of nitric oxide synthase inhibition.

Endurance training in rats with chronic heart failure induced by myocardial infarction.

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II.

Role of angiotensin II in hemodynamic responses to dynamic exercise in miniswine.

Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.

NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?

Effects of sympathetic nerve blockade on vasoconstrictive properties of nitric oxide synthase inhibition in sheep.

P304

574-581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/JAPPL.1999.87.2.574

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10444615

http://www.w3.org/2001/XMLSchema#string

P921